Signal active
Organization
Contact Information
Overview
Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery. They discover a new category in therapeutics. The company is developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.
About
Biotechnology, Life Science, Ediscovery, Product Research
2014
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Platelet BioGenesis headquartered in United States, North America, operates in the Biotechnology, Life Science, Ediscovery, Product Research sector. The company focuses on Biotechnology and has secured $29.6B in funding across 224 round(s). With a team of 11-50 employees, Platelet BioGenesis is actively contributing to advancements in Biotechnology. Their latest funding round, Debt Financing - Platelet BioGenesis, raised $1.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
14
0
0
$132.1M
Details
7
Platelet BioGenesis has raised a total of $132.1M in funding over 7 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2019 | Early Stage Venture | |||
2015 | Seed | |||
2021 | Early Stage Venture | 75.5M | ||
2017 | Early Stage Venture | 10.0M |
Investors
Platelet BioGenesis is funded by 33 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Vivo Capital | - | FUNDING ROUND - Vivo Capital | 10.0M |
Ecoast Angel Network | - | FUNDING ROUND - Ecoast Angel Network | 10.0M |
Viventures | - | FUNDING ROUND - Viventures | 10.0M |
Platelet BioGenesis | - | FUNDING ROUND - Platelet BioGenesis | 10.0M |
Recent Activity
There is no recent news or activity for this profile.